Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Norgine (Three OTC Products)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of three medical products. The OTC products are Pyralvex (pain relief), Spasmonal and Waxsol (ear drop).

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Hogehilweg 7
  • Amsterdam Zuid-Oost
  • Amsterdam
  • Netherlands

Norgine (Three OTC Products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Norgine (Three OTC Products)‘s full profile, request access.

Request full access to PitchBook

Norgine (Three OTC Products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Norgine (Three OTC Products)‘s full profile, request access.

Request full access to PitchBook